Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3beta Inactivationby: Tina M Thornton, Gustavo Pedraza-Alva, Bin Deng, David C Wood, Alexander Aronshtam, James L Clements, Guadalupe Sabio, Roger J Davis, Dwight E Matthews, Bradley Doble, Mercedes Rincon
Science, Vol. 320, No. 5876. (2 May 2008), pp. 667-670.
|
Reviews
[Write a review of this article]
There are no reviews of this article
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
AbstractGlycogen synthase kinase 3 (GSK3) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3 activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3 by phosphorylation at the N terminus, preventing Akt-mediated phosphorylation does not affect the cell-survival pathway activated through the GSK3 substrate -catenin. Here, we show that p38 mitogen-activated protein kinase (MAPK) also inactivates GSK3 by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of -catenin. p38 MAPK-mediated phosphorylation of GSK3 occurs primarily in the brain and thymocytes. Activation of -catenin-mediated signaling through GSK3 inhibition provides a potential mechanism for p38 MAPK-mediated survival in specific tissues. 10.1126/science.1156037
BibTeX record
RIS record